Skip to main content
Top
Published in: Intensive Care Medicine 5/2015

01-05-2015 | What's New in Intensive Care

Ten tips on how to win the war against resistance to antibiotics

Author: Jean Carlet

Published in: Intensive Care Medicine | Issue 5/2015

Login to get access

Excerpt

Antibiotic resistance has increased dramatically in the past few years and nowadays represents a serious threat to public health [13]. Reasons are multiple, the excess in antibiotic consumption being the most important one. Therefore, antibiotic prescription must be carefully discussed for each patient. Unfortunately, antibiotic prescription is still considered as a trivial act in both humans and animals, in both the hospitals and community. Antibiotic resistance is a worldwide issue. The prevalence of Enterobacteriaceae resistant to third generation cephalosporins reaches 70–80 % in several countries, the prevalence of carbapenemases in Klebsiella pneumoniae being more than 50 % in many countries [4, 5] (Fig. 1). In the ESAC network in Europe [6], antibiotic consumption in the community ranges from 11 to 32 DDDs per 1,000 inhabitants per day. Similar differences are seen in other continents. Between 2000 and 2010, consumption of antibiotics increased in 71 countries by 36 %, Brazil, Russia, India, China and South Africa accounting for 76 % of this increase [7]. Animal consumption represents 80 % of total antibiotic consumption. Large differences are seen in the consumption in animals [8]. In Europe, France and The Netherlands were the highest consumers. The Netherlands has been able to reduce its consumption by more than 60 % and France by 35 % in the last 5 years.
Literature
1.
go back to reference Laxminarayan R, Duse A, Wattal C (2013) Antibiotic resistance. The need for global solutions. Lancet Infect Dis 13:1057–1098CrossRefPubMed Laxminarayan R, Duse A, Wattal C (2013) Antibiotic resistance. The need for global solutions. Lancet Infect Dis 13:1057–1098CrossRefPubMed
2.
go back to reference Piddock LJ (2012) The crisis of no new antibiotics-what is the way forward. Lancet Infect Dis 12:249–253CrossRefPubMed Piddock LJ (2012) The crisis of no new antibiotics-what is the way forward. Lancet Infect Dis 12:249–253CrossRefPubMed
5.
go back to reference Nordmann P, Poirel L (2014) The difficult-to-control spread of carbapenemases producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 20:821–830CrossRefPubMed Nordmann P, Poirel L (2014) The difficult-to-control spread of carbapenemases producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 20:821–830CrossRefPubMed
7.
go back to reference Van Boeckel TP, Gandra S, Ashok A et al (2014) Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 14:742–750CrossRefPubMed Van Boeckel TP, Gandra S, Ashok A et al (2014) Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 14:742–750CrossRefPubMed
8.
go back to reference Grave K, Torren-Edo J, Mackay D (2010) Comparison of the sales of veterinary antibacterial agents between 10 European countries. J Antimicrob Chemother 65:2037–2040CrossRefPubMed Grave K, Torren-Edo J, Mackay D (2010) Comparison of the sales of veterinary antibacterial agents between 10 European countries. J Antimicrob Chemother 65:2037–2040CrossRefPubMed
9.
go back to reference Timsit JF, Harbarth S, Carlet J (2014) De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU. Intensiv Care Med 40:1580–1582CrossRef Timsit JF, Harbarth S, Carlet J (2014) De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU. Intensiv Care Med 40:1580–1582CrossRef
10.
go back to reference Bouadma L, Luyt CE, Tubach F et al (2010) Use or procalcitonin to reduce patients’exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375:463–474CrossRefPubMed Bouadma L, Luyt CE, Tubach F et al (2010) Use or procalcitonin to reduce patients’exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375:463–474CrossRefPubMed
11.
go back to reference Climo MW, Wong ES et al (2013) Daily chlorhexidine bathing and hospital-acquired infections. N Engl J Med 368:2332–2338CrossRefPubMed Climo MW, Wong ES et al (2013) Daily chlorhexidine bathing and hospital-acquired infections. N Engl J Med 368:2332–2338CrossRefPubMed
13.
go back to reference Carlet J, Collignon P, Goldmann D et al (2011) Society’s failure to protect a precious resource: antibiotics. Lancet 378:369–371CrossRefPubMed Carlet J, Collignon P, Goldmann D et al (2011) Society’s failure to protect a precious resource: antibiotics. Lancet 378:369–371CrossRefPubMed
14.
go back to reference Carlet J, Pulcini C, Piddock LJ (2014) Antibiotic resistance: a geo-political issue. Clin Microbiol Infect (Epub ahead of print) Carlet J, Pulcini C, Piddock LJ (2014) Antibiotic resistance: a geo-political issue. Clin Microbiol Infect (Epub ahead of print)
Metadata
Title
Ten tips on how to win the war against resistance to antibiotics
Author
Jean Carlet
Publication date
01-05-2015
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 5/2015
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-014-3594-z

Other articles of this Issue 5/2015

Intensive Care Medicine 5/2015 Go to the issue